HCPCS Code C9072

Injection, immune globulin (asceniv), 500 mg

Temporary Codes for Use with Outpatient Prospective Payment System

C9072 is a valid 2024 HCPCS code for Injection, immune globulin (asceniv), 500 mg or just “Inj, imm glob asceniv” for short, used in Other medical items or services.

HCPCS Code Details - C9072

HCPCS Level II Code
Temporary Codes for Use with Outpatient Prospective Payment System
HCPCS Code C9072
Description

Long description:
Injection, immune globulin (asceniv), 500 mg

Short description:
Inj, imm glob asceniv

HCPCS Modifier1
HCPCS Pricing indicator 53 - Statute
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Statute number 1833(T)
Coverage code D - Special coverage instructions apply
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service 9 - Other medical items or services
Effective date Effective Apr 01, 2021
Date added Added Jan 01, 2021
Termination date Mar 31, 2021
HCPCS Coding Procedures

HCPCS Modifiers

In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.

Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
“NU” identifies the hospital bed as new equipment

See also

  • HCPCS C9071 · Injection, viltolarsen, 10 mg

  • HCPCS J1459 · Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg

  • HCPCS J1551 · Injection, immune globulin (cutaquig), 100 mg

  • HCPCS J1554 · Injection, immune globulin (asceniv), 500 mg

  • HCPCS J1555 · Injection, immune globulin (cuvitru), 100 mg

  • HCPCS J1556 · Injection, immune globulin (bivigam), 500 mg

  • HCPCS J1557 · Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg

  • HCPCS J1558 · Injection, immune globulin (xembify), 100 mg

  • HCPCS J1559 · Injection, immune globulin (hizentra), 100 mg

  • HCPCS J1561 · Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg

  • HCPCS J1562 · Injection, immune globulin (vivaglobin), 100 mg

  • HCPCS J1566 · Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg

  • HCPCS J1568 · Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg

  • HCPCS J1569 · Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg

  • HCPCS J1572 · Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg

  • HCPCS J1575 · Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin

  • HCPCS C9073 · Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”